Thu 24 Sep 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Updated Section | Month |
|---|---|---|---|
| OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESILATE | SEVIKAR HCT | 4.4 Special warnings and precautions for use 4.8. Undesirable effects | Jun, 2026 |
| Valproate Sodium | Epilim Chrono | 4.2 Posology and Method of Administration 6.6 Special Precautions for Disposal and Handling | Jun, 2026 |
| Marstacimab | HYMPAVZI | 4.8. Undesirable effects | Jun, 2026 |
| Liraglutide | Victoza | 4.8. Undesirable effects | Jun, 2024 |
| Infliximab | Renflexis | 4.8. Undesirable effects | July, 2026 |
| IPTACOPAN | Fabhalta | 4.5 Interaction with other medicinal products and other forms of interaction | July, 2026 |
| Methotrexate | Metoject | 4.6 Fertility, pregnancy and lactation | Jul, 2025 |
| Rosuvastatin,Ezetimibe | Lipocomb | 4.5. Interactions with other medicinal products | Jul, 2024 |
| Insulin Degludec,Liraglutide | Xultophy | 4.8 Undesirable effects | Jul, 2024 |
| Belimumab | Benlysta | 4.4 Special Warnings and Special Precautions for Use | Feb,2023 |
Last update date: 07/09/2026 at 07:51 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.